CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study
作者
Rahul Mudumba,Xiaofan Liu,Jorge J. Nieva,John A. Romley
出处
期刊:Value in Health [Elsevier BV] 日期:2025-12-01卷期号:28 (12): S51-S52